WallStreetZenWallStreetZen

NASDAQ: IMV
Imv Inc Stock

Open Broker Account
$0.25-0.04 (-13.79%)
Updated Dec 8, 2022
IMV Price
$0.25
Fair Value Price
$0.51
Market Cap
$20.56M
52 Week Low
$0.24
52 Week High
$1.53
P/E
-0.68x
P/B
-4.46x
P/S
269.21x
PEG
N/A
Dividend Yield
N/A
Revenue
$154.01k
Earnings
-$31.14M
Gross Margin
100%
Operating Margin
-19,478.27%
Profit Margin
-19,478.2%
Debt to Equity
-6.11
Operating Cash Flow
-$26M
Beta
0.96
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IMV Overview

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IMV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IMV ($0.25) is undervalued by 51.36% relative to our estimate of its Fair Value price of $0.51 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
IMV ($0.25) is significantly undervalued by 51.36% relative to our estimate of its Fair Value price of $0.51 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
IMV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IMV due diligence checks available for Premium users.

Be the first to know about important IMV news, forecast changes, insider trades & much more!

IMV News

Valuation

IMV fair value

Fair Value of IMV stock based on Discounted Cash Flow (DCF)
Price
$0.25
Fair Value
$0.51
Undervalued by
51.36%
IMV ($0.25) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IMV ($0.25) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IMV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IMV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.68x
Industry
13.31x
Market
21.39x

IMV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-4.46x
Industry
4.98x

IMV's financial health

Profit margin

Revenue
$89.4k
Net Income
-$6.8M
Profit Margin
-7,570.3%
IMV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
IMV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$24.4M
Liabilities
$29.2M
Debt to equity
-6.11
IMV's short-term assets ($20.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IMV's long-term liabilities ($20.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IMV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IMV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.7M
Investing
-$175.0k
Financing
$1.1M
IMV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IMV vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
IMV$20.56M-13.79%-0.68x-4.46x
ARDS$20.60M0.00%-0.55x-0.57x
FBRX$20.79M-0.50%-1.29x0.49x
KTRA$20.82M+25.29%-0.70x2.16x
CANF$20.19M-1.45%-1.25x2.04x

Imv Stock FAQ

What is Imv's quote symbol?

NASDAQ: IMV) Imv trades on the NASDAQ under the ticker symbol IMV. Imv stock quotes can also be displayed as NASDAQ: IMV.

If you're new to stock investing, here's how to buy Imv stock.

What is the 52 week high and low for Imv (NASDAQ: IMV)?

(NASDAQ: IMV) Imv's 52-week high was $1.53, and its 52-week low was $0.24. It is currently -83.66% from its 52-week high and 5.93% from its 52-week low.

How much is Imv stock worth today?

(NASDAQ: IMV) Imv currently has 82,221,063 outstanding shares. With Imv stock trading at $0.25 per share, the total value of Imv stock (market capitalization) is $20.56M.

Imv stock was originally listed at a price of $6.88 in Jun 1, 2018. If you had invested in Imv stock at $6.88, your return over the last 4 years would have been -96.37%, for an annualized return of -56.34% (not including any dividends or dividend reinvestments).

How much is Imv's stock price per share?

(NASDAQ: IMV) Imv stock price per share is $0.25 today (as of Dec 8, 2022).

What is Imv's Market Cap?

(NASDAQ: IMV) Imv's market cap is $20.56M, as of Dec 9, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Imv's market cap is calculated by multiplying IMV's current stock price of $0.25 by IMV's total outstanding shares of 82,221,063.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.